{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-298277","form_type":"8-K","ticker":"CRSP","cik":"0001674416","company_name":"CRISPR Therapeutics AG","filed_at":"2021-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.597228+00:00","generated_at":"2026-06-28T20:51:42.653079+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CRISPR Therapeutics appoints Brendan Smith as CFO; Michael Tomsicek retires","bullets":["Brendan Smith named SVP & CFO effective Oct 14, 2021; succeeds Michael Tomsicek who retired.","Smith previously CFO at Translate Bio (acquired by Sanofi for $3.2B) and partner at BCG.","Smith receives $435K base salary, 40% bonus target, 90K options and 15K RSUs with standard vesting.","Tomsicek to remain in advisory role through Dec 31, 2021; his departure not due to any accounting disagreement."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-298277","json":"https://secwatch.observer/filing/0001193125-21-298277.json","markdown":"https://secwatch.observer/filing/0001193125-21-298277.md","text":"https://secwatch.observer/filing/0001193125-21-298277.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674416/000119312521298277/0001193125-21-298277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674416/000119312521298277/d212374d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T20:51:42.653079+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4362715360","claim":"Brendan Smith was appointed as Senior Vice President and Chief Financial Officer at CRISPR Therapeutics AG.","evidence_excerpt":"On October 14, 2021, CRISPR Therapeutics AG (the “Company”) announced the hiring and appointment of Brendan Smith as its Senior Vice President and Chief Financial Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312521298277/0001193125-21-298277-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Senior Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}